Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorM.D. Anderson Cancer Center

About this trial

The primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of health-related quality of life and other areas such as COVID-19 specific psychological distress, and disruptions to health care, finances and social interactions. We will also evaluate the extent to which resiliency factors such as social support, perceived benefits under times of stress, and ability to manage stress may buffer associations between COVID-19 experiences and HRQoL. To meet these objectives, we have developed a 10-minute questionnaire that taps into these areas and is based on prior work addressing concerns of other pandemics or national crises. Participants will have previously consented to protocol PA15-0336 and have provided prior lifestyle data. This will allow us to connect the COVID-19 survey data with prior existing data.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients who have signed consent for PA15-0336

Has an active email address and can be contacted via MyChart

Documentation of being alive per the cancer registry

Disqualifiers

None

Trial population

Patients who have signed consent for PA15-0336.

Trial design

Design model

Case-only

Time perspective

Cross-sectional

Treatments tested in this trial

  • Survey Administration

    Other intervention

    Complete survey

Treatment groups

1,152 Participants
are divided into 1 treatment group
Group A: Observational (survey administration)1 intervention

Trial outcomes

Primary outcomes

1

Experiences during the COVID-19 pandemic

Including exposure, risk factors, testing, isolation, seropositivity, hospitalization, or loss of family or friends.

Time frame
Survey completion Up to 2 months
2

COVID-19-specific psychological distress

Time frame
Survey completion Up to 2 months
3

COVID-19-specific health

Time frame
Survey completion Up to 2 months
4

COVID-19-specific financial and social disruptions

Time frame
Survey completion Up to 2 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

M.D. Anderson Cancer Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator